4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-054512
Chief Executive Officer sold 10,240 shares at $0.80 ($8,151)
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-03 | Sale : show line 1 in the form | −10,240 | $0.80 | $8,151 | 792,695 | D |
| Open-market sales · 10,240 sh · avg $0.80 · $8,151 | ||||||
Loading xslF345X05/ownership.xml…